Cargando…
Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery
BACKGROUND: The efficacy of mesenchymal stem cell (MSC) transplantation in ischemic stroke might depend on the timing of administration. We investigated the optimal time point of MSC transplantation. After MSC treatment, we also investigated the expression of matrix metalloproteinases (MMPs), which...
Autores principales: | Nam, Hyo Suk, Kwon, Il, Lee, Bo Hyung, Kim, Haejin, Kim, Jayoung, An, Sunho, Lee, Ok-Hee, Lee, Phil Hyu, Kim, Hyun Ok, Namgoong, Hyun, Kim, Young Dae, Heo, Ji Hoe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670145/ https://www.ncbi.nlm.nih.gov/pubmed/26637168 http://dx.doi.org/10.1371/journal.pone.0144218 |
Ejemplares similares
-
Correction: Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery
por: Nam, Hyo Suk, et al.
Publicado: (2016) -
The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase‐2 on Extracellular α‐Synuclein Aggregates in Parkinsonian Models
por: Oh, Se Hee, et al.
Publicado: (2016) -
Carnosine Protects against Cerebral Ischemic Injury by Inhibiting Matrix-Metalloproteinases
por: Kim, Eun-Hye, et al.
Publicado: (2021) -
Relationship Between Sleep Apnea and Coronary Artery Calcium in Patients With Ischemic Stroke
por: Cho, Kyoo Ho, et al.
Publicado: (2019) -
Body Mass Index and Prognosis in Ischemic Stroke Patients With Type 2 Diabetes Mellitus
por: Park, Hyungjong, et al.
Publicado: (2019)